论文部分内容阅读
目的 :对比探讨肝癌诊断中CT和MRI的应用价值。方法 :将2014年3月—2015年3月我院收治的68例肝癌患者纳入本次研究,以所选诊断方法的不同分为两组,A组34例实施CT诊断,B组34例实施MRI诊断,进一步对两种诊断方法的结果进行对比评估。结果 :A组34例患者中,检出阳性33例、CT无表现1例。检出阳性33例中,误诊1例,敏感性为97.06%(33/34),阳性预测值为96.97%(32/33)。B组34例患者中,检出阳性30例、CT无表现4例。检出阳性30例中,误诊3例,敏感性88.24%(30/34),阳性预测值为90.00%(27/30)。A组敏感性与阳性预测值均显著高于对照组,两组数据差异有统计学意义(P<0.50)。结论 :肝癌诊断中,CT诊断价值优于MRI,敏感性及阳性预测值均更高,因此值得采纳应用。
Objective: To compare the value of CT and MRI in the diagnosis of liver cancer. Methods: Sixty-eight patients with HCC who were admitted to our hospital from March 2014 to March 2015 were enrolled in this study. The patients were divided into two groups according to the selected diagnostic methods. 34 cases in group A were diagnosed by CT, 34 cases in group B MRI diagnosis, and further comparison of the results of the two diagnostic methods. Results: Among the 34 patients in group A, 33 cases were positive and 1 case was CT non-appearance. Among the 33 positive cases, 1 was misdiagnosed, the sensitivity was 97.06% (33/34), and the positive predictive value was 96.97% (32/33). Among 34 patients in group B, 30 were positive and 4 were non-CT. Among the 30 positive cases, 3 cases were misdiagnosed, the sensitivity was 88.24% (30/34), and the positive predictive value was 90.00% (27/30). The sensitivity and positive predictive value of group A were significantly higher than that of control group, the difference between the two groups was statistically significant (P <0.50). Conclusion: The diagnostic value of CT in diagnosis of liver cancer is better than that of MRI, and the sensitivity and positive predictive value are higher, so it is worth to adopt.